Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus | Zendy

Marina Michurova | Zendy; Ирина Владимировна Кононенко | Zendy; Olga Mikhailovna Smirnova | Zendy; Victor Yur'evich Kalashnikov | Zendy

Open Access

Effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes in patients with type 2 diabetes mellitus

Author(s) -

Marina Michurova,

Ирина Владимировна Кононенко,

Olga Mikhailovna Smirnova,

Victor Yur'evich Kalashnikov

Publication year - 2014

Publication title -

diabetes mellitus

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.155

H-Index - 12

eISSN - 2072-0378

pISSN - 2072-0351

DOI - 10.14341/dm2014134-40

Subject(s) - medicine , diabetes mellitus , percutaneous coronary intervention , myocardial infarction , cardiology , revascularization , type 2 diabetes mellitus , type 2 diabetes , psychological intervention , intervention (counseling) , disease , endocrinology , psychiatry

of drug-eluting stents for percutaneous coronary interventions opened novel options for treating coronary heart disease (CHD) in patients with diabetes mellitus. However, mortality and myocardial infarction rates are still higher among diabetes patients. They also require repeated revascularization of the target vessel more often than euglycemic individuals do. Current review discusses possible effects of diabetes compensation by various classes of antihyperglycemic agents on endovascular intervention outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research